MedArchitex Prevent
For health plans and risk-bearing organizations seeking earlier signals of chronic disease progression, preventable hospitalization, care gaps, and barriers to adherence.
Preventive intelligence for responsible teams
Earlier signals. Better-directed action.
MedArchitex supports organizations working to prevent disease and understand treatment journeys, while keeping the patient, permitted use, and model evidence visible.
MedArchitex Evidence
For life sciences teams studying pre-diagnosis cohorts, progression, treatment pathways, access barriers, adherence, trial feasibility, and real-world outcomes.
Patient permission remains explicit
An organization does not inherit the patient view. Sharing for care, research, or organizational use is specific, visible, revocable, and recorded.
Prediction should increase care
Risk intelligence is designed to support earlier help and better evidence. It is not designed for coverage exclusion, premium setting, or reducing access to treatment.
Useful with existing data
The intelligence layer can work with claims, clinical records, laboratory data, prescriptions, and carefully governed external context without replacing core systems.
Evidence before scale
Each deployment should define intended use, validation population, performance monitoring, human review, and the actions a result is allowed to support.
The MedArchitex standard